Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Wai Yuen Tong Medicine Holdings Ltd
Change in Working Capital
Wai Yuen Tong Medicine Holdings Ltd
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
|
Change in Working Capital
HK$232.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Change in Working Capital
-HK$594.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Change in Working Capital
-ÂĄ1.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Change in Working Capital
-ÂĄ1.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Change in Working Capital
-HK$705.2m
|
CAGR 3-Years
47%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Change in Working Capital
$114.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
22%
|
CAGR 10-Years
37%
|
See Also
What is Wai Yuen Tong Medicine Holdings Ltd's Change in Working Capital?
Change in Working Capital
232.6m
HKD
Based on the financial report for Sep 30, 2023, Wai Yuen Tong Medicine Holdings Ltd's Change in Working Capital amounts to 232.6m HKD.
What is Wai Yuen Tong Medicine Holdings Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
2%
Over the last year, the Change in Working Capital growth was 28%. The average annual Change in Working Capital growth rates for Wai Yuen Tong Medicine Holdings Ltd have been 2% over the past three years .